Uterine fibroids are a common reproductive condition of many assigned females at birth. It's estimated that about 20% to 80% of women will develop fibroids by the time they turn fifty years old. Most uterine fibroid cases are found in women in their forties and early fifties. While fibroids affect many women, there's little research about this women's reproductive health issue causing many women to suffer in silence with the condition, especially Black/African American women impacted at a higher rate by this medical condition than any other demographic.

It's common for many women to find it difficult to orgasm. There's a psychological, emotional, and physical aspects to sex, and any of these variables can interfere with an individual's ability to reach orgasm. Most commonly, when a woman has trouble reaching orgasm, it's due to a lack of understanding of the female anatomy and the absence of communication of pleasure and needs in the bedroom between partners. However, this may not always be the reason why you're falling short when experiencing a sexual climax. Sexual dysfunction is as common in women as it is in men. But it's also important to note that there could be many issues as to why a woman may not orgasm. Besides orgasmic dysfunction that can affect women sexually and cause female sexual dysfunction, other ailments can play a role in the dissatisfaction of a woman's sex life. For example, these ailments can include low libido, painful sex, difficulty in arousal, or an aversion to sex. These are a few of many variables that are common and real issues that can cause women distress and affect their relationships. The good news is there are many medical treatments available that women don't know about that can help with their orgasm difficulties. Currently, the most popular medical option is the Orgasm Shot, most commonly known as the O-shot. Today, we will answer all your questions about the O-shot's benefits and risks.

According to WHO, Hepatitis C is a bloodborne virus that is transmitted through contact with blood from an infected person. Hepatitis C infection has emerged as a global health crisis. It is one of the major global causes of death. Data indicates that over the last decade, its seroprevalence has doubled to over 2.8%, which relates to approximately 190 million infections globally. Hepatitis C exhibits a unique genetic diversity characterized by different genotype mutations, which poses a challenge in improving and developing pan-genotypic treatment and vaccines.